Pilot study to determine Time in HYpoglycaemia when using pre-MixEd (biphasic) insulin

Abbott Diabetes Care Ltd0 个研究点目标入组 43 人开始时间: 2019年5月22日最近更新: 2022年8月5日

试验速览

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34464470/ (added 01/07/2022)

•1. Aged 18 years or over.
•2. Type 2 diabetes treated with pre-mixed (biphasic) insulin for at least 6 months prior to study enrolment.
•3. Most recent HbA1c less than 7.5% (58 mmol/mol), recorded in medical notes in last 12 months.

•1. Currently prescribed animal insulin.
•2. Concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition.
•3. Has a pacemaker or any other neurostimulators.
•4. Currently receiving dialysis treatment or planning to receive dialysis during the study.
•5. Women who are pregnant, plan to become pregnant or become pregnant during the study.
•6. Participating in another study of a glucose monitoring device or drug that could affect glucose measurements or management.
•7. Known (or suspected) allergy to medical grade adhesives.
•8. In the investigator’s opinion, unsuitable to participate due to any other cause/reason.

发起方

Abbott Diabetes Care Ltd